Defects in the APC gene are inarguably linked to the progression of co
lon cancers that arise both sporadically and through the transmission
of germline mutations. Genetic evidence from humans and mouse models s
uggest that APC is a classic tumor suppressor in that both alleles lik
ely require inactivation for tumor growth to ensue, Nearly all of the
mutations, germline and somatic, result in premature termination of:he
single polypeptide chain, normally consisting of 2843 amino acids. Se
veral definable motifs have now been mapped to the linear amino acid s
equence of the APC polypeptide. These include an oligomerization domai
n, armadillo repeats, binding sites for beta-catenin, the human discs
large protein, microtubules, and other proteins of unknown function. I
nactivation of APC in cancer is likely due to loss of function(s) norm
ally associated with the deleted protein structure.